Suneel Narayanavari
Senior Scientist at NanoCell Therapeutics, Inc.- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Boris Nowotny
Suneel is an excellent scientist!
Boris Nowotny
Suneel is an excellent scientist!
Boris Nowotny
Suneel is an excellent scientist!
Boris Nowotny
Suneel is an excellent scientist!
Credentials
-
The Entrepreneurial Mindset
edXJan, 2017- Nov, 2024
Experience
-
Nanocell Therapeutics
-
Netherlands
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Senior Scientist
-
Jul 2021 - Present
Founding member of the company and program lead responsible for developing SOPs, establishing work flows related to CAR T cell generation and functional assays. Developing technology platform for engineering T cells in vivo using T cell targeted nanoparticles for the delivery of nucleic acids encoding chimeric antigen receptor (CAR), that has the potential to transform CAR T cell therapies. Founding member of the company and program lead responsible for developing SOPs, establishing work flows related to CAR T cell generation and functional assays. Developing technology platform for engineering T cells in vivo using T cell targeted nanoparticles for the delivery of nucleic acids encoding chimeric antigen receptor (CAR), that has the potential to transform CAR T cell therapies.
-
-
-
Universitätsklinikum Würzburg
-
Germany
-
Hospitals and Health Care
-
700 & Above Employee
-
Postdoctoral Scientist
-
Oct 2019 - Jun 2021
Development and optimization of CAR T cell manufacturing process using viral (LV) and non-viral (Sleeping Beauty transposon system) approaches. Proficient in genetic modification of primary T cells using nucleofection/electroporation approaches (Lonza 4D nucleofector; MaxCyte) for the delivery of therapeutic DNA (plasmids or minicircles), or RNA or protein. Engineering CAR NK-92 cells using Sleeping Beauty (SB) transposon system. Development and optimization of CAR T cell manufacturing process using viral (LV) and non-viral (Sleeping Beauty transposon system) approaches. Proficient in genetic modification of primary T cells using nucleofection/electroporation approaches (Lonza 4D nucleofector; MaxCyte) for the delivery of therapeutic DNA (plasmids or minicircles), or RNA or protein. Engineering CAR NK-92 cells using Sleeping Beauty (SB) transposon system.
-
-
-
Rutgers University–New Brunswick
-
United States
-
Higher Education
-
700 & Above Employee
-
Technology Transfer Intern, Office of Research and Commercialization
-
Oct 2018 - Sep 2019
Evaluation of invention disclosures and intellectual property (IP) due diligence by working within a team of licensing managers to identify commercial product scenarios, market potential and potential licenseesTechnology assessment and preparation of summaries, marketing materials and marketing campaigns
-
-
Postdoctoral Research Associate
-
Jul 2018 - Sep 2019
Managed an NIH project involving designing experiments, data analysis and establishing collaborations with other scientistsContributed in establishing the new lab, SOPs and study design / grant writing
-
-
Executive Board Member of the Postdoctoral Association
-
Jul 2018 - Dec 2018
Contributed in organizing 2 events targeted for postdocs as a campus activities coordinator and generated sponsorship funding by working in a team of 7 other board members
-
-
-
Max Delbrück Center
-
Germany
-
Research Services
-
500 - 600 Employee
-
Post-doctoral Research Scientist
-
Mar 2013 - Apr 2018
Led a team of 4 members to develop enhanced Sleeping Beauty transposon technology for cell and gene therapy applications that resulted in a patent (PCT/EP2017/056133) Published 5 research articles including an expert insight article highlighting applications of Sleeping Beauty transposon technology, patent landscape, commercialization, licensing deals and exploitation by spin-off companies Contributed in grant writing including planning and designing of a project involving an innovative technology with applications in gene and cell therapy that resulted in funding Show less
-
-
-
AstraZeneca
-
United Kingdom
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Research Trainee - Summer Internship
-
May 2006 - Aug 2006
Collaboratively worked in a team of 3 people to purify protein for drug discovery and development process targeting tuberculosis. Trained in drug discovery and development process. Collaboratively worked in a team of 3 people to purify protein for drug discovery and development process targeting tuberculosis. Trained in drug discovery and development process.
-
-
Education
-
2007 - 2013
University of Hyderabad
Doctor of Philosophy (PhD), Life Sciences -
2005 - 2007
University of Mysore
Master's Degree, Biochemistry
Community
